As of 2026-06-19, the Intrinsic Value of Aldeyra Therapeutics Inc (ALDX) is -2.27 USD. This ALDX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.83 USD, the upside of Aldeyra Therapeutics Inc is -223.97%.
Based on its market price of 1.83 USD and our intrinsic valuation, Aldeyra Therapeutics Inc (ALDX) is overvalued by 223.97%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.27 - -2.27 | -2.27 | -223.97% |
| P/E | (6.53) - (7.67) | (7.10) | -488.0% |
| DDM - Stable | (3.07) - (10.13) | (6.60) | -460.5% |
| DDM - Multi | (3.23) - (8.72) | (4.76) | -360.3% |
| Market Cap (mil) | 110.39 |
| Beta | 2.83 |
| Outstanding shares (mil) | 60.32 |
| Enterprise Value (mil) | 60.68 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.20% |
| Cost of Debt | 5.00% |
| WACC | 10.25% |